✦ LIBER ✦

Lixisenatide treatment improves glycaemic control in Asian patients with type 2 diabetes mellitus inadequately controlled on metformin with or without sulfonylurea: a randomized, double-blind, placebo-controlled, 24-week trial (GetGoal-M-Asia)

✍ Scribed by Yu Pan, Chang ;Han, Ping ;Liu, Xiaoming ;Yan, Shengli ;Feng, Ping ;Zhou, Zhiguang ;Lv, Xiaofeng ;Tian, Hui ;Jin Kui, Yang ;Su, Benli ;Shang, Shuhua ;Niemoeller, Elisabeth

Book ID: 121857608
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 650 KB
Volume: 30
Category: Article
ISSN: 1520-7552
DOI: 10.1002/dmrr.2541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Dapagliflozin add-on to metformin in typ

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

✍ Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 827 KB

Effect of dapagliflozin in patients with

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial

✍ K. Strojek; K. H. Yoon; V. Hruba; M. Elze; A. M. Langkilde; S. Parikh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Dutogliptin, a selective DPP4 inhibitor,

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial

✍ H. M. R. Pattzi; S. Pitale; M. Alpizar; C. Bennett; A. M. O’Farrell; J. Li; J. M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Dose-dependent effects of the once-daily

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Efficacy and safety of treatment with si

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

✍ R. Arechavaleta; T. Seck; Y. Chen; K. J. Krobot; E. A. O’Neill; L. Duran; K. D. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB